Slavnov V N, Luchinskiĭ E V
Probl Endokrinol (Mosk). 1981 Jul-Aug;27(4):17-21.
The results are presented of investigation on prolactin secretion in 30 patients with Icenko-Cushing's disease in the active stage and during remission, resultant of the treatment with the adrenocortical secretion inhibitor chloditan. The changes in the blood prolactin concentration were determined on the empty stomach by radioimmunoassay in the presence of insulin hypoglycemia with simultaneous thyroliberin injection. It was found that prolactin basal level in the blood increased and the hypophyseal reaction to stress, induced by insulin hypoglycemia and thyroliberin injection in the active stage of Icenko-Cushing's disease, reduced. Hypophyseal reaction to stimulants was considerably lowered in males versus females. Clinical remission of chloditan-treated Icenko-Cushing's disease was not accompanied by the blood prolactin basal level decrease and hypophyseal reaction improvement to stimulants.
本文展示了对30例处于活动期和缓解期的艾辛柯-库欣病患者催乳素分泌的调查结果,这些结果是使用肾上腺皮质分泌抑制剂氯地孕酮治疗后的结果。通过在空腹状态下,在胰岛素低血糖且同时注射促甲状腺素释放激素的情况下,采用放射免疫分析法测定血催乳素浓度的变化。研究发现,在艾辛柯-库欣病活动期,血液中催乳素基础水平升高,垂体对胰岛素低血糖和促甲状腺素释放激素注射所诱导的应激反应降低。男性垂体对刺激物的反应比女性明显降低。氯地孕酮治疗的艾辛柯-库欣病临床缓解并未伴随血催乳素基础水平降低以及垂体对刺激物反应的改善。